Chemistry and biology of indoles and indazoles: A mini-review

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 12, 2013, Pages 1792-1800

  Ali, Nasir Ali Shafakat ^a   Dar, Bashir Ahmad ^a,b   Pradhan, Vidya ^a   Farooqui, Mazahar ^a  

^a Dr Rafiq Zakaria College for Women   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Biological activities; Indazoles; Indoles

Indexed keywords

(3 (1 ETHYL 1H INDAZOL 3 YL) 2 PHENYLQUINAZOLIN 4(3H) ONE); 1 ((S) 2 AMINIPROPYL) IH INDAZOLE 6 OL; 1 [2 (3, 3 DIMETHYLBUTYL) 4 (TRIFLUOROMETHYL) BENZYL] 3 (1 METHYL 4 INDAZOLYL) UREA; 1 [2 (3,3 DIMETHYLBUTYL) 4 (TRIFLUOROMETHYL)BENZYL] 3 (1 METHYL 4 INDAZOLYL)UREA; 1 P CHLOROBENZYL 1HINDAZOLE 3 CARBOXYLIC ACID; 1H INDAZOLE 3 CARBOXYLIC ACID DERIVATIVE; 2,3 DISUBSTITUTED 3,3A,4,5,6,7 HEXAHYDRO 2H INDAZOLE DERIVATIVE; 4 AROYLINDOLE DERIVATIVE; 4 FLUORO AND 4 METHOXY 1 (4 BEN ZOYL PIPERAZIN 1 YL) 2 (1H INDOL 3 YL) ETHANE 1, 2 DIONE; 5 AROYLINDOLE DERIVATIVE; 5 METHYL N (3 OXO 1 THIA 4 AZASPIRO[4 5]DEC 4 YL) 3 PHENYL 1H INDOLE 2 CARBOXAMIDE; BENZIMIDAZOLE; GRANISETRON; GUANYLATE CYCLASE ACTIVATOR; INDALPINE; INDAZOLE DERIVATIVE; INDOLE 3 OXIME; INDOLE DERIVATIVE; INDOMETACIN; INDOPROFEN; LONIDAMINE; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; POTASSIUM HYDROXIDE; RESERPINE; SEROTONIN; SODIUM; SUMATRIPTAN; TEMOZOLOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1 ANTAGONIST; VINDOLINE;

ACUTE LEUKEMIA; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; AUTOINFLAMMATORY DISEASE; BIOLOGICAL ACTIVITY; BRAIN CANCER; CARDIOVASCULAR DISEASE; CHEMISTRY; ERECTILE DYSFUNCTION; HODGKIN DISEASE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NAUSEA AND VOMITING; NEOPLASM; NONHUMAN; ORGANIC CHEMISTRY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMS BIOLOGY;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; ESCHERICHIA COLI; HUMANS; INDAZOLES; INDOLES; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE; PROTEIN BINDING;

EID: 84888052268     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313120009     Document Type: Review

References (105)

1. David, B. C.; Fariborz, M.; John, S. H. Mercury (11)-Mediated Opening of Cyclopropanes. Effects of Proximate Internal Nucleophiles on Stereo-and Regioselectivity. J. Am. Chem. SOC. 1983, 105, 6882-6889.
2. Baeyer, A.; Emmerling. A. Synthese des Indols. Chem. Ber, 1869, 2, 679-682.
3. Van Order, R. B.; Lindwall H. G. Indole. Chem. Rev, 1942, 30, 69-96.
4. Joule, J. A. In Science of Synthesis, Thomas, E. J., Ed., Thieme: Stuttgart, Vol. 10 (2000).
5. Gribble, G. W. J. Chem. Soc., Perkin Trans, 2000, 1, 1045-1075.
6. S. Hibino, T. Choshi, Nat. Prod. Rep, 2002, 19, 148-180.
7. Douglass F. Taber, Pavan K. Tirunahari Indole synthesis: a review and proposed classification. Tetrahedron, 2011, 67, 7195-7210.
8. Moreau, Pascale. Synthesis and biological evaluation of diversely substituted indolin-2-ones. Eur. J. Med. Chem. 2008, 43, 2316-2322.
9. Mohammad, A; Sadique, A. J.; Harish, K. Synthesis and biological evaluation of some 4-(1H-indol-3-yl)-6-phenyl-1, 2, 3, 4-tetrahydropyrimidin-2-ones/thiones as potent antiinflammatory agents", Acta Pharm, 2008, 58, 467-477.
10. Nadeem, S. M.; Shamsher, A.; Waquar, A. Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl) acetyl-N-(substituted phenyl) hydrazine carbothioamides and their related heterocyclic derivatives" Acta Pharm, 2008, 58, 445-454.
11. Pandeya, S. N.; Yogeeswari, P.; Sriram, D.; Nath, G. Synthesis and antimicrobial activity of N-Mannich bases of 3-N'-sulphadoximinoisatin and its methyl derivative. Boll. Chim. Farm. 1998, 137, 321-324.
12. Dharmendra, K.; Narendra, K.; Sandeep, K.; Tarun, S.; Singh, C. P. Synthesis of pharmacologically active 2-phenyl sulpha/substituted Indoles. Int. J. Eng. Sci. and Tech. 2010, 2(7), 2553-2557.
13. John, L.; Agnes, H.; Fritz, L.; Urs, V.; Thomas, B. Amino-terminal sequence of ethylene-induced bean leaf chitinase reveals similarities to sugar-binding domains of wheat germ agglutinin. FEBS, 1985, 193, 208-210.
14. Omar, F. A.; Mahfouz, N. M.; Rahman, M. A. Design, synthesis and antiinflammatory activity of some 1, 3, 4-oxadiazole derivatives. Eur. J. Med. Chem. 1996, 31, 819-825.
15. Ajam, C. S.; Chinpiao, C. An Easy and Efficient Synthesis of Bisindolylmethanes and Tetraindolylmethane Tröger's Base Catatlyzed by AgBF. J. Chin. Chem. Soc. 2011, 58, 899-905.
16. Flower, R. J.; Moncada, S.; Vane, J. R.; Goodman and Gilman's The Pharmacological Basis of Therapeutics, seventh Ed., 695, 1985.
17. Misra, U.; Hitkari, A.; Saxena, A. K.; Gurtu, S.; Shanker, K.; Biologically active indolylmethyl-1, 3, 4-oxadiazoles, 1, 3, 4,-thiadiazoles, 4H-1, 3-4-triazoles and 1, 2, 4-triazines. Eur. J. Med. Chem. 1996, 31, 629-634.
18. Andreani, A. M.; Rambaldi, A.; Locatelli, G.; Pifferi, Synthesis and antiinflammatory activity of indolylacrylic and methylacrylic acids. Eur. J. Med. Chem, 1994, 29, 903-906.
19. Chavan, R.; More, H. N. Synthesis and Biological Evaluation of Novel Series of 1-(4, 5-Dihydropyrazolyl)-Indoles. Der Pharmacia Lettre, 2012, 4 (4), 1236-1245.
20. Rani P., Srivastava V. K., Kumar A. Synthesis and antiinflammatory activity of heterocyclic indole derivatives. Eur. J. Med. Chem, 2004, 39, 449-452.
21. Dubey, P. K.; Venkateshwar, K. T.; Raddanna, P.; Anil, K. K. Synthesis of [2-(3-oxo-3, 4-dihydro-2H-benzo[1, 4]oxazin-6-carbonyl)-1H-indol-3-yl]acetic acids as potential COX-2 inhibitors. Indian J. Chem. B, 2006, 45, 2128-2132.
22. Agarwal, R.; Agarwal, C.; Singh, C.; Misra, V. S. Synthesis of 1-(2-arylindol-3yl)-2[3-(p-morpholinophenyl)-6, 8-disubstituted-quinazolin-4(3H)-one-2yl]ethenes as CNS active and anti-inflammatory agents. J. Chem. Soc. Pak, 1984, 6, 89-94.
23. Verma, M.; Tripathi, M.; Saxena, A. K.; Shanker, K. Antiinflammatory activity of novel indole derivatives. Eur. J. Med. Chem, 1994, 29, 941-946.
24. Deepak, K.; Agarwal, R. C.; Ashok, K. Synthesis of new indole congeners as promising anti-inflammatory agents. Oriental Journal of Chemistry 2010, 26(2), 455-466.
25. Sunakar, P.; JAGAT, K. T. Comparative Study of Inclusion Complexes of Orthosubstituted [Arylidenamino]-1, 3, 4-thiadiazino [6, 5b]Indole Derivatives. E-Journal of Chemistry 2012, 9(3), 1213-1222.
26. Mohamed, R. A. A.; Ragab, E. A.; Sabry, N. M.; Shenaw, E. S. M. Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents. Bioorg. Med. Chem, 2007, 15, 3832-3841.
27. Zheng, M. F.; Zheng, M.; Deng, D. Y.; Oils, S.; Luo, X.; Chen, K.; Liu, H.; Jiang, H. Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling. Bioorg. Med. Chem. Lett, 2007, 17, 2414-2420.
28. Sharma, P.; Kumar, A.; Pandey, P. A facile synthesis of N-phenyl-6-hydroxy-3-bromo-4-arylazo quinolin-2-ones under phase transfer catalytic conditions and studies on their antimicrobial activities. Indian J. Chem. B, 2006, 45, 2077-2082.
29. Panwar, R. S.; Verma, H.; Srivastava, V. K.; Kumar, A. Synthesis of some substituted azetidinonyl and Thiazolidinonyl-1, 3, 4-thiadiazino [6, 5-6]indole as protective antimicrobial agents. Ind. J. Chem. B, 2006, 2099-2104.
30. Bhusare S. R., Shinde A. B., Pawar R. P., Vibhute Y. B. Synthesis and antimicrobial activity of heterocyclic Schiff bases, 4-thiazolidinones and 2-azetidinones Ind. J. Pharm. Sci, 2004, 3, 228-231.
31. Dandia, A.; Sehgal, V.; Singh, P. Synthesis of fluorine containing 2-aryl-3-pyrazolyl/pyranyl/isoxazolinyl indole derivatives as antifungal and antibacterial agents. Ind. J. Chem. B, 1993, 32, 1288-1291.
32. Holla, B. S.; Udupa, K. V. Synthesis and antibacterial activity of nitrofurfuraldehyde as-triazino [5, 6-b]indol-3-ylhydrazones. J. Ind. Chem. Soc, 1988, 65 (7), 524-525.
33. Archna, R. P.; Baja, j K.; Chandra, R.; Kumar, A. Synthesis of Newer Indolyl/Phenothiazinyl Substituted 2-Oxo/Thiobarbituric Acid Derivatives as Potent Anticonvulsant Agents. Arzneim.-Forsch./Drug Res. 2003, 301-306.
34. Archna Rani P., Srivastava V. K, Kumar A. Synthesis of newer indolyl thiadiazoles and their thiazolidinones and formazans as potential anticonvulsant agents. Indian J. Pharm. Sci. 2003, 65 (4): 356-362.
35. Danawade, S. D.; Raghu, A. V. S.; Gadaginamath, G. Synthesis and antimicrobial activity of novel linearly fused 5-substituted-7-acetyl-2, 6-dimethyloxazolo[4, 5-m]indoles. Indian J. Heterocl Chem, 2007, 46B, 690-693.
36. Mohamed, A. A.; Radwan, E. A.; Ragab, M. R. S.; Ahmed O. H. E. Application of (2Z)-3-dimethylamino-2-(1H-indole-3-carbonyl) acrylonitrile in the synthesis of novel 3-heteroarylindoles: condensed meridianine analogs. ARKIVOC 2009, (vii) 281-291.
37. Dubey, P. K. Balaji, B. Synthesis of 2-Heteryl substituted indoles. Indian J. Heterocl Chem. 2007, 16, 357-360.
38. Bru-Magniez, N.; Guenger, T.; Tenton J. M. (Laboratories UPSA. Fr.) U. S. U 5, 480, 983 (Cl. 536-27, 62; C07H19/167), 2 Jan 1996, FR Appl. 92/138, 8 Jan 1992; 30 pp. Cont-in-part of U. S. 5, 229, 505 (Eng.) Chem. Abstr, 1996, (17), 124.
39. Kuethe, J. T.; Wong, A.; Smitrovich, C.; Qu, J. Davies I. W., Hughes D. L. Synthesis of 5-substituted-1H-indol-2-yl-1H-quinolin-2-ones: a novel class of KDR kinase inhibitors. J. Org. Chem, 2005, 70, 2555-2567.
40. Van Zandt, M. C.; Jones, M. L.; Gunn, D. E.; Geraci, L. S.; Jones, J. H.; Sawicki, D. R.; Sredy, J.; Jacot, J. L.; Dicioccio, A. T.; Petrova, T.; Mitschler, A.; Podjarny, A. D. Discovery of 3-[(4, 5, 7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J. Med. Chem, 2005, 48, 3141-3152.
41. Li, J. J.; Gribble, G. W.; Baldwin, J.; Williams (Eds.) R. M., ch-3. Indoles, tetrahedron Organic Chemistry Series 2000, 20, 73-181.
42. Glennon, R. A. Central serotonin receptors as targets for drug research. J. Med. Chem, 1987, 30, 1-12.
43. Hiari, Y. M. A.; Qaisi, A. M.; Abadelah M. M.; Voelter, W. Synthesis and Antibacterial Activity of Some Substituted 3-(Aryl)-and 3-(Heteroaryl)indoles. Monatshefte. Fur Chemie, 2006, 137, 243.
44. Tao, W. John, F. K.; Zhongxing, Z.; Zhiwei, Y.; Qi, G.; Dedong, W.; Dawn, D.; Giugno, P.; Zheng, Y.; Lisa, Z.; Brett, A. R.; Yi-Fei, G.; Wade, S. B.; Pei-Yong, S.; Gregory, Y.; Pin-Fang, L.; Nicholas, A. M. Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives. Bioorg. Med. Chem. Lett, 2009, 19, 5140-5145.
45. Hong, B. C.; Jiang, Y.; Chang, Y.; Lee, S. Synthesis and Cytotoxicity Studies of Cyclohepta[b]indoles, Benzo[6, 7]cyclohepta[1, 2-b]indoles, Indeno[1, 2-b]indoles, and Benzo[a]carbazole. J. Chin. Chem. Soc, 2006, 53, 647.
46. Enein, H. Y. A.; Kruk, I.; Lichszteld, K.; Michalska, T.; Kiadna, A.; Marczynski, S.; Olgen, S. Scavenging of reactive oxygen species by N-substituted indole-2 and 3-carboxamides Luminescence. 2004, 19, 1.
47. Bhovi, G. M.; Gadaginamath; S. G. Synthesis and antimicrobial activity of some new 1-[2-phenylthioethyl]1-[2-phenoxyethyl]-3-ethoxycarbonyl-5-methoxy-2-methylindoles/benz[e]indoles. Indian J. Heterocl Chem. 2004, 13, 293-296.
48. Kalaskar, G. P.; Girisha, M.; Purohit, M. G.; Thippeswamy, B. S.; Patil, B. M. Synthesis and evaluation of in vivo anti-inflammatory activity of indole-3-aceetic acids. Indian J. Heterocycl. Chem. 2007, 16, 325.
49. Joshi, K. C.; Pathak, V. N.; Chand, P. Synthesis and CNS Activity of Some Fluorine Containing 3-Indolylglyoxamides and Tryptamines. Agric. Bioi. Chem. 1978, 42(9), 1723-1727.
50. Li, Y. Y.; Wu, H. S.; Tang, L.; Feng, C. R.; Yu, H. Y.; Yang, Y. S.; Yang, B. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. J. Pharmacol. Res. 2007, 56, 335.
51. Abele, E.; Abele, R.; Dzenitis, O.; Lukevics. E. Indole and Isatin Oximes: Synthesis, Reactions, and Biological Activity. Chem. Heterocycl. Compd, 2003, 39, 3.
52. Jing-Ping, L.; Chang-Ying, W.; Hsing-Pang, H.; Chi-Yen, C.; Chi-Ming, C.; Ching-Chuan, K.; Jang-Yang, Chang. 4-and 5-aroylindoles as novel classes of potent antitubulin agents J. Med. Chem. 2007, 50 (18), 4548-4552.
53. Ozlen, G.; Nalan, T. L.; Gultaze, C.; Aydi, S. Synthesis and biological evaluation of new 5-methyl-N-(3-oxo-1-thia-4-azaspiro [4. 5]-dec-4-yl)-3-phenyl-1H-indole-2-carboxamide derivatives. ARKIVOC, 2006, (xii) 98-110.
54. Konkel, M. J.; Lagu, B.; Boteju, L. W.; Jimenez, H.; Noble, S.; Walker, M. W.; Koirnberg, B. E.; Gregory, T.; Pugsley, T. A.; Zoski, K.; Wise, L. D. 3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonists. J. Med. Chem. 2006, 49, 3757.
55. Neelakandan Vidhya Lakshmi, Prakasam Thirumurugan, Noorulla K. M. and Paramasivan T. Perumal. InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives, Bioorg. Med. Chem. Lett, 2010, 20, 5054-5061.
56. Elguero J., Katritzky A. R., Rees C. W., in Comprehensive Heterocyclic Chemistry, Ed., Pergamon Press: Oxford, 5, 167-303, 1984.
57. Rodrigues de Sa Alves F., Barreiro E. J., Fraga C. A. M. From nature to drug discovery: the indole scaffold as a 'privileged structure' Mini-Rev. Med. Chem, 2009, 9, 782-793.
58. Abele, E.; Abelem, R.; Dzenitis, O.; Lukevics, E. Indoles & isatin oximes: Synthesis, reactions and bilogical activity. Chem. Heterocycl. Compd. 2003, 39, 3-35.
59. Bhattacharya, S.; Chaudhuri, P. Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes. Curr. Med. Chem. 2008, 15(13), 1762-1777.
60. Alamgir, M.; Black, D. S.; Kumar, N. Synthesis, Reactivity and Biological Activity of Benzimidazoles. Top. Heterocycl. Chem. 2007, 9, 87-118.
61. Boaini, M.; Gonlalez, M. Imidazole and benzimidazole derivatives as chemotherapeutic agents. Mini-Rev. Med. Chem. 2005, 5, 409-424.
62. Atta-ur, R.; Malik, S.; He, C.; Clardy, J. Isolation and structure determination of nigellicine, a novel alkaloid from the seeds of nigella sativa. Tetrahedron Lett. 1985, 26, 2759-2762.
63. Liu, Y. M.; Yang, J. S.; Liu, Q. H. A new alkaloid and its artificial derivative with an indazole ring from Nigella glandulifera. Chem. Pharm. Bull. 2004, 52, 454-455.
64. Atta-ur, R.; Malik, S.; Hasan, S. S.; Choudhary, M. I.; Ni, C. Z. Clardy Nigellidine. A new indazole alkaloid from the seeds of Nigella sativa. Tetrahedron Lett, 1995, 36, 1993-1996.
65. Cerecetto H., Gerpe A., Gonzalez M., Aran V. J., Ochoa de Ocariz C. Pharmacological properties of indazole derivatives: recent developments. Mini Rev. Med. Chem. 2005, 5, 869-878.
66. Silvestrini B., Baiocchi L. (Aziende Chimiche Riunite Angelini Francesco (ACRAF) S. p. A., Italy). GB 2110532, CA 99: 93777.
67. Sanger, G. J.; Nelson, D. R. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). Eur. J. Pharmacal. 1989, 159, 113-124.
68. Hesketh, P. I.; Gandara, D. R. Serotonin Antagonists: A New Class of Antiemetic Agents. J. Natl. Cancer Inst. 1991, 83(45), 613-620.
69. Kharitonov, V. G.; Sharma, V. S.; Magde, D.; Koesling, D. Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1. Biochemistry, 1999, 38, 10699-10706.
70. Cerrada, M. L.; Elguero, J.; De La Fuente, J.; Pardo, C.; Ramos, M. Synthesis of p-nitrophenylazoles by phase transfer catalysis without solvent. Synthetic Communications, 1993, 23, 1947-1952.
71. Wu C. C.; Ko, F. N.; Kuo, S. C.; Lee, F. Y.; Teng, C. M. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. J. Pharmacol. 1995, 116, 1973-1978.
72. Dudak, S. D.; Lopez, A.; Block, N. L.; Lokeshwar, B. L. Enhancement of radiation response of prostatic carcinoma by lonidamine. Anticancer Res, 1996, 16, 3665-3671.
73. Corsi, G.; Palazzo, G.; Germani, C.; Barcellona, P. S.; Silvestrini, B. 1-Halobenzyl-1H-indazole-3-carboxylic acids. A new class of antispermatogenic agents. J. Med. Chem. 1976, 19, 778-783.
74. Forster, R.; Campana, A.; D'Onofrio, E.; Henderson, L.; Mosesso, P.; Scorza B. P. Lonidamine: a non-mutagenic antitumor agent. Carcinogenesis, 1990, 11, 1509-1515.
75. Prabhakara, S.; Kalia, V. K. Optimizing radiotherapy of brain tumours by a combination of temozolomide & lonidamine. Ind. J. Med. Res, 2008, 128, 140-148.
76. Qian, S.; Cao, J.; Yan, Y.; Sun, M.; Zhu, H.; Hu, Y.; He, Q.; Yang, B. SMT-A07, a 3-(Indol-2-yl) indazole derivative, induces apoptosis of leukemia cells in vitro. Molecular and Cellular Biochemistry, 2010, 345, 13-21.
77. Souers, A. R.; Gao, J.; Brune, M.; Bush, E.; Wodka, D.; Vasudevan, A.; Judd, A. S.; Mulhern, M.; Brodjian, S.; Dayton, B.; Shapiro, R.; Hernandez, L. E.; Marsh K. C.; Sham. H. L.; Collins, C. A.; Kyrn, P. R. Identification of 2-(4-benzyloxyphenyl)-N-[1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melaninconcentrating hormone receptor 1 antagonist for the treatment of obesity. J. Med. Chem, 2005, 48, 1318-1321.
78. Stadlbauer, W. In Houben-Weyl, Methoden der Organischen Chemie: Indazole (Benzopyrazole), Schaumann E., Ed., Georg-Thieme-Verlag Stuttgart: New York, E8b, Hetarenes III/2, 764-864, 1994.
79. Stadlbauer, W. In Science of Synthesis: Indazoles, Neier, R., Ed., Georg-Thieme-Verlag Stuttgart: New York, 2. 12. 4 (Hetarenes), 227-324, 2002.
80. Ikeda, Y.; Takano, N.; Matsushita, H.; Shiraki, Y.; Koide, T.; Nagashima R.; Fujimura, Y.; Shindo, M.; Suzuki, S.; Iwasaki, T. Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32). Arzneim.-Forsch, 1979, 29, 511-520.
81. Picciola, G.; Ravenna, F.; Carenini, G.; Gentili, P.; Riva, M. Heterocyclic compounds containing a 4-aminophenylalkanoic acid residue with potential antiinflammatory activity IV. Derivatives of 2-phenyl-2H-indazole. Farmaco Ed. Sci, 1981, 36, 1037-1056.
82. th edition; Budavari, S., Ed, Merck & Co.: Rahway, New Jersey, 1996.
83. Mosti L., Menozzi G., Fossa P., Schenone P., Lampa E., Parrillo C., D'Amisco M., Rossi F., 4-substituted 1-methyl-1H-indazoles with analgesic, antiinflammatory and antipyretic activities. Farmaco, 1992, 47, 567-584.
84. Andronati, S.; Sava, V.; Makan, S.; Kolodeev, G. Synthesis of 3-aryl-1-[(4-phenyl-1-piperazinyl)butyl]indazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors. Pharmazie, 1999, 54, 99-101.
85. Kharitonov, V. G., Sharma, V. S.; Magde, D.; Koesling, D.; Kinetics and equilibria of soluble guanylate cyclase ligation by CO: Effect of YC-1. Biochemistry, 1999, 38, 10699-10706.
86. Rodgers, J. D.; Johnson, B. L.; Wang, H.; Greenberg, R. A.; Erickson-Viitanen, S.; Klabe, R. M.; Cordova, B. C.; Rayner, M. M.; Lam, G. N.; Chang, C. H. Potent cyclic urea HIV protease inhibitors with benzofused heterocycles as P2/P2 groups. Bioorg. Med. Chem. Lett, 1996, 6, 2919-2924.
87. Sun, J. H.; Teleha, C. A.; Yan, J. S.; Rodgers, J. D.; Nugiel, D. A. Efficient Synthesis of 5-(Bromomethyl)-and 5-(Aminomethyl)-1-THP-Indazole. J. Org. Chem, 1997, 62, 5627-5629.
88. 3 Receptor Antagonist. Synth. Commun, 1997, 27, 559-566.
89. Bermudez, J.; Fake, C. S.; Joiner, G. F.; Joiner, K. A.; King, F. D.; Miner, W. D.; Sanger, G. J. 5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives. J. Med. Chem, 1990, 33, 1924-1929.
90. Jesse, A.; May, A.; Nura, P.; Dantanarayana, P. W.; Zinke, M. A. M.; Najam A. S. 1-(S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. J. Med. Chem, 2006, 49(1), 318-328.
91. Salvatore, P.; Demetrio, R.; Fabiana, P.; Giovanni, C.; Benedetta, M.; Giuseppe, D.; Maria, Valeria, R.; Maria, G. C.; Gabriella, B.; Fiorella, M.; ARKIVOC, 2010, (x) 163-177.
92. Vyas, D. H.; Tala, S. D.; Akbari, J. D.; Dhaduk, M. F.; Joshi, H. S. Synthesis and antimicrobial activity of some new cyanopyridine and cyanopyrans towards Mycobacterium tuberculosis and other microorganisms. Ind. J. Chem. B, 2009, 48, 1405-1410.
93. Brian, S.; Brown, R. K.; Richard, J. P.; Stanley, D.; John, R. K.;, Tammie, K. J.; Steven, M. H.; Heath, A. M.; Bruce, R. B.; Prisca Honore, P. S.; Puttfarcken, R. B. M.; Kennan, C. M.; Connie, R. F.; Chih-Hung, L. Bioorg. Med. Chem. Let, 2010, 20, 113291-3294.
94. Silvestrini, B.; Burberi, S.; Catanese, B.; Cioli, V.; Coulston, F.; Lisciani, R.; Barcellona, P. S. Antispermatogenic activity of 1-pchlorobenzyl-1H-indazol-3-carboxylic acid (AF 1312/TS) in rats. I. Trials of single and short-term administrations with study of pharmacologic and toxicologic effects. Mol. Pathol, 1975, 23, 288-307.
95. Corsi, G.; Palazzo, G.; Germani, C.; Barcellona, P. S.; Silvestrini, B. 1-Halobenzyl-1H-indazole-3-carboxylic acids. A new class of antispermatogenic agents. J. Med. Chem, 1976, 19, 778-783.
96. Caputo, A.; Silvestrini, B. Lonidamine, a new approach to cancer therapy. Oncology, 1984, 41, 2-6.
97. Di Cosimo, S.; Ferretti, G.; Papaldo, P.; Carlini, P.; Fabi, A, Cognetti, F. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc). 2003, 39(3), 157-74.
98. Locke, K. W.; Dunn, R. W.; Hubbard, J. W.; Vanselous, C. L.; Cornfeldt, M.; Stuart, F.; Strupczewski, J. T. Studies on the synthesis and rearrangement of indazolylpyridinium. Drug Development Research, 1990, 19, 239-256.
99. Matthew, S. S.; Mitchell, J. S. The renaissance of palladium(II)-catalyzed oxidation chemistry. Org Biomol Chem. 2004, 2(18), 2551-2554.
100. Kawakubo, H.; Sone, T.; Wakigawa, K.; Narita, T. Antiinflammatory, analgesic properties and antipyretic action of 3-aminoindazole derivatives. Yakugaki Zasshi, 1987, 107, 28-36.
101. Mosti, L.; Sansebastiano, L.; Fossa, P.; Schenone, P.; Mattioli, F. 1-Phenyl-1H-indazole derivatives with analgesic and antiinflammatory activities. Farmaco, 1992, 47, 357-365.
102. Menon, S.; Vaidya, H.; Pillai, S.; Vidya, R.; Mitscher, L. A. A parallel synthesis demonstration library of tri-substituted indazoles containing new antimutagenic/antioxidant hits related to benzylamine. Combinatorial chemistry and high throughput screening, 2003, 6, 79-99.
103. Claramunt, R. M.; Concepcion, L.; Carlos, P.; Marta, P.; Jose, E.; Germaine, E.; Dario, A. Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation. Bioorg. Med. Chem, 2009, 17, 6180-6187.
104. Maninder, M. T.; Sharad, R. W.; Shyam, S. A.; Balasubramanian, N. Synthesis, antimicrobial activity and QSAR studies of new 2, 3-disubstituted-3, 3a, 4, 5, 6, 7-hexahydro-2H-indazoles. Bioorg. Med. Chem. Lett, 2009, 19, 2960-2964.
105. Mei, B.; Grant, C.; Russell, J. D.; Thomas, D.; Friedrich, S. D.; Kevin, F.; Peter, R. G.; Douglas B. K.; Michael, A. L.; Denise, P.; Mohammed, S.; Alexander U.; Mark A. W. 5-Functionalized indazoles as glucocorticoid receptor agonists. Bioorg. Med. Chem. Lett, 2010, 20, 3017-3020.